Literature DB >> 11334397

Fulminant Mycoplasma pneumoniae pneumonia.

Y Takiguchi1, N Shikama, N Aotsuka, H Koseki, T Terano, A Hirai.   

Abstract

A 64-year-old woman, who was previously in good health was admitted because of progressive respiratory distress. Her chest radiograph revealed bilateral widespread alveolar infiltrates. She was given a diagnosis of pneumonia caused by Mycoplasma pneumoniae serologically, acute respiratory distress syndrome, and disseminated intravascular coagulation. She died of multiple organ failure despite intensive therapy with mechanical ventilation, intravenous erythromycin and corticosteroids, continuous hemodiafiltration, and plasma exchange. Although Mycoplasma pneumoniae infection is usually a benign self-limited disease, this case emphasizes its potentially serious nature even in normal healthy individuals.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11334397     DOI: 10.2169/internalmedicine.40.345

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  14 in total

1.  Chlamydia pneumoniae and Mycoplasma pneumoniae pneumonia: comparison of clinical, epidemiological characteristics and laboratory profiles.

Authors:  I Puljiz; I Kuzman; O Dakovic-Rode; N Schönwald; B Mise
Journal:  Epidemiol Infect       Date:  2005-11-29       Impact factor: 2.451

2.  The efficacy of glucocorticoid on macrolide resistant Mycoplasma pneumonia in children.

Authors:  Jae-Won Oh
Journal:  Allergy Asthma Immunol Res       Date:  2013-12-23       Impact factor: 5.764

Review 3.  Novel aspects on the pathogenesis of Mycoplasma pneumoniae pneumonia and therapeutic implications.

Authors:  Takeshi Saraya; Daisuke Kurai; Kazuhide Nakagaki; Yoshiko Sasaki; Shoichi Niwa; Hiroyuki Tsukagoshi; Hiroki Nunokawa; Kosuke Ohkuma; Naoki Tsujimoto; Susumu Hirao; Hiroo Wada; Haruyuki Ishii; Koh Nakata; Hirokazu Kimura; Kunihisa Kozawa; Hajime Takizawa; Hajime Goto
Journal:  Front Microbiol       Date:  2014-08-11       Impact factor: 5.640

4.  Cytokines as the good predictors of refractory Mycoplasma pneumoniae pneumonia in school-aged children.

Authors:  Yuanyuan Zhang; Shufen Mei; Yunlian Zhou; Meixia Huang; Guijuan Dong; Zhimin Chen
Journal:  Sci Rep       Date:  2016-11-11       Impact factor: 4.379

5.  Early diagnosis and appropriate respiratory support for Mycoplasma pneumoniae pneumonia associated acute respiratory distress syndrome in young and adult patients: a case series from two centers.

Authors:  Lin Ding; Yu Zhao; Xuyan Li; Rui Wang; Ying Li; Xiao Tang; Bing Sun; Hangyong He
Journal:  BMC Infect Dis       Date:  2020-05-24       Impact factor: 3.090

6.  The Clinical Characteristics and Predictors of Refractory Mycoplasma pneumoniae Pneumonia in Children.

Authors:  Yuanyuan Zhang; Yunlian Zhou; Shuxian Li; Dehua Yang; Xiling Wu; Zhimin Chen
Journal:  PLoS One       Date:  2016-05-26       Impact factor: 3.240

Review 7.  Clinical Features of Severe or Fatal Mycoplasma pneumoniae Pneumonia.

Authors:  Koichi Izumikawa
Journal:  Front Microbiol       Date:  2016-06-01       Impact factor: 5.640

8.  The early examination of combined serum and imaging data under flexible fiberoptic bronchoscopy as a novel predictor for refractory Mycoplasma pneumoniae pneumonia diagnosis.

Authors:  Le Wang; Sukun Lu; Zhishan Feng; Lanfeng Li; Bo Niu; Jinfeng Shuai; Lijie Cao; Guixia Li; Jianhua Liu
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

9.  Unexplained Dyspnea in a Young Adult with Epstein-Barr Virus Infectious Mononucleosis: Pulmonary Involvement or Co-Infection with Mycoplasma pneumoniae Pneumonia?

Authors:  Burke A Cunha; Scarlet Herrarte Fornos
Journal:  J Clin Med       Date:  2017-09-04       Impact factor: 4.241

10.  Methylprednisolone pulse therapy for refractory Mycoplasma pneumoniae pneumonia in children.

Authors:  Akihiro Tamura; Kousaku Matsubara; Takayuki Tanaka; Hiroyuki Nigami; Kazuo Yura; Takashi Fukaya
Journal:  J Infect       Date:  2008-07-25       Impact factor: 6.072

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.